
Bot L. Ledynh
Examiner (ID: 7484, Phone: (571)272-2231 , Office: P/2858 )
| Most Active Art Unit | 2858 |
| Art Unit(s) | 2103, 2858, 2862, 2899, 2831 |
| Total Applications | 2040 |
| Issued Applications | 1805 |
| Pending Applications | 55 |
| Abandoned Applications | 180 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9602623
[patent_doc_number] => 20140199305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-17
[patent_title] => 'PROTEIN COMPRISING TRUNCATED FORM OF EXTRACELLULAR REGION PROTEIN OF FRIZZLED2, AND PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES SAID PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 14/127654
[patent_app_country] => US
[patent_app_date] => 2012-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 21091
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14127654
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/127654 | Protein comprising truncated form of extracellular region protein of Frizzled 2, and pharmaceutical composition for treating bone diseases which comprises said protein | Jun 20, 2012 | Issued |
Array
(
[id] => 9490644
[patent_doc_number] => 20140141050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'BIORESORBABLE WOUND DRESSING'
[patent_app_type] => utility
[patent_app_number] => 14/128185
[patent_app_country] => US
[patent_app_date] => 2012-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8718
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14128185
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/128185 | Bioresorbable wound dressing | Jun 20, 2012 | Issued |
Array
(
[id] => 8671546
[patent_doc_number] => 20130046085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'ANTIBODIES AGAINST N-PROCALCITONIN'
[patent_app_type] => utility
[patent_app_number] => 13/527069
[patent_app_country] => US
[patent_app_date] => 2012-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8650
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13527069
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/527069 | ANTIBODIES AGAINST N-PROCALCITONIN | Jun 18, 2012 | Abandoned |
Array
(
[id] => 8854132
[patent_doc_number] => 20130143807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'Concentrated Protein Preparations of Bone Morphogenetic Proteins and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/490989
[patent_app_country] => US
[patent_app_date] => 2012-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13904
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13490989
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/490989 | Concentrated Protein Preparations of Bone Morphogenetic Proteins and Methods of Use Thereof | Jun 6, 2012 | Abandoned |
Array
(
[id] => 9602622
[patent_doc_number] => 20140199304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-17
[patent_title] => 'METHODS FOR REPAIRING TISSUE DAMAGE USING PROTEASE-RESISTANT MUTANTS OF STROMAL CELL DERIVED FACTOR-1'
[patent_app_type] => utility
[patent_app_number] => 14/124187
[patent_app_country] => US
[patent_app_date] => 2012-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11122
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124187
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/124187 | Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1 | Jun 5, 2012 | Issued |
Array
(
[id] => 9634779
[patent_doc_number] => 20140212887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-31
[patent_title] => 'SCREENING METHOD FOR THERAPEUTIC AGENT FOR CHONDROPATHY AND MODIFIED CHONDROCYTE FOR TREATMENT OF CHONDROPATHY'
[patent_app_type] => utility
[patent_app_number] => 14/118971
[patent_app_country] => US
[patent_app_date] => 2012-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8339
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14118971
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/118971 | Screening method for therapeutic agent for chondropathy and modified chondrocyte for treatment of chondropathy | May 28, 2012 | Issued |
Array
(
[id] => 9545520
[patent_doc_number] => 20140170167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-19
[patent_title] => 'Inhibition of Bone Resorption with Rankl Binding Peptides'
[patent_app_type] => utility
[patent_app_number] => 14/122307
[patent_app_country] => US
[patent_app_date] => 2012-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 63562
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14122307
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/122307 | Inhibition of bone resorption with RANKL binding peptides | May 28, 2012 | Issued |
Array
(
[id] => 8393145
[patent_doc_number] => 20120230988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-13
[patent_title] => 'ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN SIGLEC-15'
[patent_app_type] => utility
[patent_app_number] => 13/481016
[patent_app_country] => US
[patent_app_date] => 2012-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 45412
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13481016
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/481016 | Antibody targeting osteoclast-related protein siglec-15 | May 24, 2012 | Issued |
Array
(
[id] => 9421694
[patent_doc_number] => 20140106345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'BIOMARKERS FOR IN VITRO PROGNOSIS AND DIAGNOSIS OF GRAFT AND TRASPLANT REJECTION'
[patent_app_type] => utility
[patent_app_number] => 14/122438
[patent_app_country] => US
[patent_app_date] => 2012-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7389
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14122438
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/122438 | BIOMARKERS FOR IN VITRO PROGNOSIS AND DIAGNOSIS OF GRAFT AND TRASPLANT REJECTION | May 23, 2012 | Abandoned |
Array
(
[id] => 8509154
[patent_doc_number] => 20120308561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-06
[patent_title] => 'POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELING'
[patent_app_type] => utility
[patent_app_number] => 13/478556
[patent_app_country] => US
[patent_app_date] => 2012-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 85
[patent_figures_cnt] => 85
[patent_no_of_words] => 34470
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13478556
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/478556 | Method for inhibiting bone resorption | May 22, 2012 | Issued |
Array
(
[id] => 11218862
[patent_doc_number] => 09447191
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-20
[patent_title] => 'Osteogenesis promoter'
[patent_app_type] => utility
[patent_app_number] => 14/117254
[patent_app_country] => US
[patent_app_date] => 2012-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 10237
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117254
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/117254 | Osteogenesis promoter | May 10, 2012 | Issued |
Array
(
[id] => 8429610
[patent_doc_number] => 20120251485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN SIGLEC-15'
[patent_app_type] => utility
[patent_app_number] => 13/457967
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 45409
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13457967
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/457967 | Antibody targeting osteoclast-related protein Siglec-15 | Apr 26, 2012 | Issued |
Array
(
[id] => 9330130
[patent_doc_number] => 20140056912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'METHODS OF TREATING SQUAMOUS CELL CARCINOMA'
[patent_app_type] => utility
[patent_app_number] => 14/114418
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18250
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14114418
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/114418 | METHODS OF TREATING SQUAMOUS CELL CARCINOMA | Apr 26, 2012 | Abandoned |
Array
(
[id] => 8344360
[patent_doc_number] => 20120205274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'ALLOGRAFT BONE COMPOSITION HAVING A GELATIN BINDER'
[patent_app_type] => utility
[patent_app_number] => 13/456461
[patent_app_country] => US
[patent_app_date] => 2012-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12011
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13456461
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/456461 | ALLOGRAFT BONE COMPOSITION HAVING A GELATIN BINDER | Apr 25, 2012 | Abandoned |
Array
(
[id] => 9462765
[patent_doc_number] => 20140127192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'METHOD FOR TREATING OSTEOPOROSIS'
[patent_app_type] => utility
[patent_app_number] => 14/112667
[patent_app_country] => US
[patent_app_date] => 2012-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19732
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112667
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/112667 | METHOD FOR TREATING OSTEOPOROSIS | Apr 17, 2012 | Abandoned |
Array
(
[id] => 9435954
[patent_doc_number] => 20140113861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-24
[patent_title] => 'CARTILAGE PRODUCT'
[patent_app_type] => utility
[patent_app_number] => 14/112679
[patent_app_country] => US
[patent_app_date] => 2012-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11003
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112679
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/112679 | Cartilage product | Apr 15, 2012 | Issued |
Array
(
[id] => 8660067
[patent_doc_number] => 20130040896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/447091
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 23318
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13447091
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/447091 | Compositions comprising ALK1-ECD protein | Apr 12, 2012 | Issued |
Array
(
[id] => 8659081
[patent_doc_number] => 20130039910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/447077
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 23250
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13447077
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/447077 | METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITION | Apr 12, 2012 | Abandoned |
Array
(
[id] => 11677162
[patent_doc_number] => 09675670
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-13
[patent_title] => 'System and method for multiphasic release of growth factors'
[patent_app_type] => utility
[patent_app_number] => 14/111518
[patent_app_country] => US
[patent_app_date] => 2012-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8944
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111518
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/111518 | System and method for multiphasic release of growth factors | Apr 10, 2012 | Issued |
Array
(
[id] => 8927923
[patent_doc_number] => 20130183683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'METHODS OF DIAGNOSING ACUTE CARDIAC DISORDERS USING BNP-SP'
[patent_app_type] => utility
[patent_app_number] => 13/439841
[patent_app_country] => US
[patent_app_date] => 2012-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19785
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13439841
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/439841 | METHODS OF DIAGNOSING ACUTE CARDIAC DISORDERS USING BNP-SP | Apr 3, 2012 | Abandoned |